Global Bioinformatics Services Market

Bioinformatics Services Market Size, Share, Growth Analysis, By Application(Genomics, Chemoinformatic & Drug Design), By Specialty(Medical, Animal) - Industry Forecast 2024-2031


Report ID: SQMIG35H2205 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 67 | Figures: 77

Bioinformatics Services Market Insights

Bioinformatics Services Market size was valued at USD 2.5 billion in 2021 and is poised to grow from USD 2.90 billion in 2022 to USD 8.14 billion by 2030, at a CAGR of 15.9% during the forecast period (2023-2030).

The global bioinformatics services market has witnessed substantial growth and holds promising prospects for the future. The market is being driven by factors such as the increasing demand for personalized medicine, advancements in genomics and proteomics research, and the growing need for efficient data management and analysis in the life sciences industry.

The rise in genomic data generated by next-generation sequencing technologies and the need to interpret and manage this vast amount of data have fueled the demand for bioinformatics services. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) algorithms in bioinformatics has further accelerated market growth, enabling the development of predictive models, drug discovery, and precision medicine.

Furthermore, the increasing adoption of cloud computing for data storage and analysis, along with the rising importance of data standardization and interoperability, are propelling the bioinformatics services market. Emerging economies are witnessing significant growth due to favorable government initiatives and investments in genomics research and bioinformatics infrastructure.

Factors such as the establishment and improvement of information and communication technology (ICT) infrastructure by organizations or the adoption of cloud computing for data services, often managed by third-party providers, to meet growing demands, are anticipated to stimulate research and development (R&D) activities in this sector.

As a result, these developments are expected to significantly impact the progress and advancement of the sector until 2024.

US Bioinformatics Services Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Bioinformatics Services Market size was valued at USD 2.5 billion in 2021 and is poised to grow from USD 2.90 billion in 2022 to USD 8.14 billion by 2030, at a CAGR of 15.9% during the forecast period (2023-2030).

These participants are engaging in strategic collaborations with various information technology companies to strengthen their market presence by offering customers improved information management solutions. 'Thermo Fisher Scientific (United States)', 'Illumina, Inc. (United States)', 'QIAGEN N.V. (Germany)', 'PerkinElmer, Inc. (United States)', 'Agilent Technologies, Inc. (United States)', 'Eurofins Scientific (Luxembourg)', 'Waters Corporation (United States)', 'Partek Incorporated (United States)', 'Biomax Informatics AG (Germany)', 'DNASTAR, Inc. (United States)', 'Geneious (New Zealand)', 'CLC bio (Qiagen) (Denmark)', 'Genedata AG (Switzerland)', 'Accelrys (Dassault Systèmes) (United States)', 'Active Motif, Inc. (United States)', 'Compugen Ltd. (Israel)', 'BioTeam, Inc. (United States)', 'BGI (China)', 'Genomatix Software GmbH (Germany)', 'Nonlinear Dynamics (Waters Corporation) (United Kingdom)', 'Seven Bridges Genomics, Inc. (United States)', 'CytoGenomics Inc. (United States)'

There is a growing emphasis on personalized medicine, which aims to provide tailored healthcare solutions based on an individual's genetic makeup and unique characteristics. Bioinformatics services play a crucial role in analyzing and interpreting genomic data to identify biomarkers, predict disease risk, and optimize treatment plans. The rising demand for personalized medicine is driving the adoption of bioinformatics services in both research and clinical settings.

Cloud computing is gaining traction in the bioinformatics domain. Cloud-based bioinformatics services offer scalability, cost-effectiveness, and ease of data access and collaboration. Researchers can leverage cloud platforms for data storage, analysis, and sharing, overcoming limitations associated with on-premises infrastructure.

North America dominates the bioinformatics services market, accounting for over a third of the total revenue. This is primarily due to a well-defined regulatory framework that encourages industry participation, leading to increased revenue generation. The simultaneous development of next-generation sequencing and chemical laboratories in the region has had a significant impact on the high penetration of drug discovery-based informatics services, further driving revenue growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bioinformatics Services Market

Product ID: SQMIG35H2205

$5,300
BUY NOW GET FREE SAMPLE